missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DZIP3 (aa 434-531) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
E3 Ubiquitin ligase proteins mediate ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Able to specifically bind RNA.
Specifications
Specifications
| Accession Number | Q86Y13 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 9666 |
| Name | Human DZIP3 (aa 434-531) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2310047C04Rik; 2 A-HUB; 6430549P11Rik; A230104G20; DAZ interacting protein 3, zinc finger; DAZ interacting zinc finger protein 3; DAZ-interacting protein 3; DAZ-interacting protein 3 homolog; DZIP3; E3 ubiquitin-protein ligase DZIP3; hRUL138; human RNA-binding ubiquitin ligase of 138 kDa; Kiaa0675; PPP1R66; protein phosphatase 1, regulatory subunit 66; RGD1563278; RING-type E3 ubiquitin transferase DZIP3; RNA-binding RING-H2 protein-ubiquitin ligase; RNA-binding ubiquitin ligase of 138 kDa; UURF2; UURF2 ubiquitin ligase; zinc finger DAZ interacting protein 3 |
| Common Name | DZIP3 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction